Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns
""
Blog |
13 April 2021

The Access Blog

""
Blog image cover
Blog
Blog |
10 September 2021
COVID-19

JAK inhibitors: promising treatment for people with severe COVID-19 illness. But will they be affordable for all?

Jérôme Tognotti, MSF nurse supervisor, holding a vial of COVID vaccine used by teams to vaccinate homeless and migrant people
Blog
Blog |
02 September 2021
COVID-19

When big pharma has all the power, what choice do countries like South Korea have?

MSF is calling on the Biden Administration to push pharmaceutical corporations Pfizer-BioNTech and Moderna to help the world rapidly scale up production of mRNA vaccines.
Blog
Blog |
26 July 2021
COVID-19

A truly “Global Britain” must stop blocking global solutions to end the COVID-19 pandemic

Felipe de Carvalho, MSF Access Campaign Advocacy Advisor, Brazil
Blog
Blog |
16 July 2021
Intellectual property and trade

Brazil’s Supreme Court delivers a groundbreaking decision in favour of access to medicines

The 8.30 AM Doctors’ meeting during the peak of the second COVID-19 wave at Ngwelezana Tertiary Hospital in South Africa’s KwaZulu-Natal Province
Blog
Blog |
07 July 2021
COVID-19

An African mRNA jab: The hub as a first step towards African vaccine independence

Obert Symon, an MoH Medical Assistant and MSF Clinical Officer Mentor Christopher Banda, are conducting a full physical examination on Austin at Ndamera Health Centre, Nsanje District.
Blog
Blog |
08 June 2021
HIV/AIDS

UN HIV declaration must throw a lifeline to people with advanced HIV disease

Salih Muhammad Auwal is a medical doctor and also the COVID-19 focal clinician at Shinkafi hospital, Zamfara state, northwest Nigeria.
Blog
Blog |
26 May 2021
COVID-19

“We are doing our part — but without vaccines we have no chance to stop this pandemic“

Din Savorn, 50, with his son during lunchtime at their apartment in Phnom Penh, Cambodia, 20, April 2017.
Blog
Blog |
30 April 2021
COVID-19

Why Canada should support the WTO waiver to expand access to COVID-19 medical technologies

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury